MARKET

NBIO

NBIO

Nascent Biotech
EXMKT
0.0045
NaN%
Closed 09:30 03/26 EDT
OPEN
--
PREV CLOSE
0.0045
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.190
52 WEEK LOW
0.0020
MARKET CAP
774.98K
P/E (TTM)
-0.3750
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at NBIO last week (0317-0321)?
Weekly Report · 2d ago
Weekly Report: what happened at NBIO last week (0310-0314)?
Weekly Report · 03/17 11:16
Weekly Report: what happened at NBIO last week (0303-0307)?
Weekly Report · 03/10 11:18
Weekly Report: what happened at NBIO last week (0224-0228)?
Weekly Report · 03/03 11:17
Weekly Report: what happened at NBIO last week (0217-0221)?
Weekly Report · 02/24 11:17
Weekly Report: what happened at NBIO last week (0210-0214)?
Weekly Report · 02/17 11:15
Weekly Report: what happened at NBIO last week (0203-0207)?
Weekly Report · 02/10 11:09
Weekly Report: what happened at NBIO last week (0127-0131)?
Weekly Report · 02/03 11:13
More
About NBIO
Nascent Biotech, Inc. is a phase II clinical-stage biopharmaceutical company, which is engaged in developing monoclonal antibodies for the treatment of various cancer types. The Company focuses on biologic drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seeks to further develop those drug candidates for commercial use. It owns a drug candidate, Pritumumab, which the Company is developing as a treatment for epithelial cancers that includes lung, breast, colon, brain, and pancreas. The Company’s initial focus is on the development of Pritumumab as an intravenous treatment of patients with various types of brain cancer, prominently gliomas and malignant astrocytoma. The Company is exploring Pritumumab in its use against viruses. The Company is also engaged in developing a traditional vaccine platform to create vaccines for viral infections.

Webull offers Nascent Biotech Inc stock information, including EXMKT: NBIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NBIO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NBIO stock methods without spending real money on the virtual paper trading platform.